1
|
Vily-Petit J, Soty M, Silva M, Micoud M, Bron C, Guérin-Deremaux L, Mithieux G. Improvement of energy metabolism associated with NUTRIOSE® soluble fiber, a dietary ingredient exhibiting prebiotic properties, requires intestinal gluconeogenesis. Food Res Int 2023; 167:112723. [PMID: 37087279 DOI: 10.1016/j.foodres.2023.112723] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2022] [Revised: 01/16/2023] [Accepted: 01/21/2023] [Indexed: 03/29/2023]
Abstract
While the prevalence of obesity progresses worldwide, the consumption of sugars and dietary fiber increases and decreases, respectively. In this context, NUTRIOSE® soluble fiber is a plant-based food ingredient with beneficial effects in Humans. Here, we studied in mice the mechanisms involved, particularly the involvement of intestinal gluconeogenesis (IGN), the essential function in the beneficial effects of dietary fibers. To determine whether NUTRIOSE® exerts its beneficial effects via the activation of IGN, we studied the effects of dietary NUTRIOSE® on the development of obesity, diabetes and non-alcoholic fatty liver disease (NAFLD), which IGN is able to prevent. To assert the role of IGN in the observed effects, we studied wild-type (WT) and IGN-deficient mice. In line with our hypothesis, NUTRIOSE® exerts metabolic benefits in WT mice, but not in IGN-deficient mice. Indeed, WT mice are protected from body weight gain and NAFLD induced by a high calorie diet. In addition, our data suggests that NUTRIOSE® may improve energy balance by activating a browning process in subcutaneous white adipose tissue. While the gut microbiota composition changes with NUTRIOSE®, this is not sufficient in itself to account for the benefits observed. On the contrary, IGN is obligatory in the NUTRIOSE® benefits, since no benefit take place in absence of IGN. In conclusion, IGN plays a crucial and essential role in the set-up of the beneficial effects of NUTRIOSE®, highlighting the interest of the supplementation of food with healthy ingredients in the context of the current obesity epidemic.
Collapse
Affiliation(s)
- Justine Vily-Petit
- Institut de la Santé et de la Recherche Médicale, U1213 Lyon, France; Université Claude Bernard Lyon1, Villeurbanne, France; Université de Lyon, Lyon, France
| | - Maud Soty
- Institut de la Santé et de la Recherche Médicale, U1213 Lyon, France; Université Claude Bernard Lyon1, Villeurbanne, France; Université de Lyon, Lyon, France
| | - Marine Silva
- Institut de la Santé et de la Recherche Médicale, U1213 Lyon, France; Université Claude Bernard Lyon1, Villeurbanne, France; Université de Lyon, Lyon, France
| | - Manon Micoud
- Institut de la Santé et de la Recherche Médicale, U1213 Lyon, France; Université Claude Bernard Lyon1, Villeurbanne, France; Université de Lyon, Lyon, France
| | - Clara Bron
- Institut de la Santé et de la Recherche Médicale, U1213 Lyon, France; Université Claude Bernard Lyon1, Villeurbanne, France; Université de Lyon, Lyon, France
| | | | - Gilles Mithieux
- Institut de la Santé et de la Recherche Médicale, U1213 Lyon, France; Université Claude Bernard Lyon1, Villeurbanne, France; Université de Lyon, Lyon, France.
| |
Collapse
|
2
|
Intestinal gluconeogenesis: metabolic benefits make sense in the light of evolution. Nat Rev Gastroenterol Hepatol 2023; 20:183-194. [PMID: 36470967 DOI: 10.1038/s41575-022-00707-6] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 10/27/2022] [Indexed: 03/02/2023]
Abstract
The intestine, like the liver and kidney, in various vertebrates and humans is able to carry out gluconeogenesis and release glucose into the blood. In the fed post-absorptive state, intestinal glucose is sensed by the gastrointestinal nervous system. The latter initiates a signal to the brain regions controlling energy homeostasis and stress-related behaviour. Intestinal gluconeogenesis (IGN) is activated by several complementary mechanisms, in particular nutritional situations (for example, when food is enriched in protein or fermentable fibre and after gastric bypass surgery in obesity). In these situations, IGN has several metabolic and behavioural benefits. As IGN is activated by nutrients capable of fuelling systemic gluconeogenesis, IGN could be a signal to the brain that food previously ingested is suitable for maintaining plasma glucose for a while. This process might account for the benefits observed. Finally, in this Perspective, we discuss how the benefits of IGN in fasting and fed states could explain why IGN emerged and was maintained in vertebrates by natural selection.
Collapse
|
3
|
Romero-Juárez PA, Visco DB, Manhães-de-Castro R, Urquiza-Martínez MV, Saavedra LM, González-Vargas MC, Mercado-Camargo R, Aquino JDS, Toscano AE, Torner L, Guzmán-Quevedo O. Dietary flavonoid kaempferol reduces obesity-associated hypothalamic microglia activation and promotes body weight loss in mice with obesity. Nutr Neurosci 2023; 26:25-39. [PMID: 34905445 DOI: 10.1080/1028415x.2021.2012629] [Citation(s) in RCA: 9] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
Abstract
BACKGROUND Obesity results from an unbalance in the ingested and burned calories. Energy balance (EB) is critically regulated by the hypothalamic arcuate nucleus (ARC) by promoting appetite or anorectic actions. Hypothalamic inflammation, driven by high activation of the microglia, has been reported as a key mechanism involved in the development of diet-induced obesity. Kaempferol (KF), a flavonoid-type polyphenol present in a large number of fruits and vegetables, was shown to regulate both energy metabolism and inflammation. OBJECTIVES In this work, we studied the effects of both the central and peripheral treatment with KF on hypothalamic inflammation and EB regulation in mice with obesity. METHODS Obese adult mice were chronically (40 days) treated with KF (0.5 mg/kg/day, intraperitoneally). During the treatment, body weight, food intake (FI), feed efficiency (FE), glucose tolerance, and insulin sensitivity were determined. Analysis of microglia activation in the ARC of the hypothalamus at the end of the treatment was also performed. Body weight, FI, and FE changes were also evaluated in response to 5µg KF, centrally administrated. RESULTS Chronic administration of KF decreased ∼43% of the density, and ∼30% of the ratio, of activated microglia in the arcuate nucleus. These changes were accompanied by body weight loss, decreased FE, reduced fasting blood glucose, and a tendency to improve insulin sensitivity. Finally, acute central administration of KF reproduced the effects on EB triggered by peripheral administration. CONCLUSION These findings suggest that KF might fight obesity by regulating central processes related to EB regulation and hypothalamic inflammation.
Collapse
Affiliation(s)
- Pedro A Romero-Juárez
- Instituto Tecnológico Superior de Tacámbaro, Michoacán, México.,Facultad de Químico-Farmacobiología, Universidad Michoacana de San Nicolás de Hidalgo, Morelia, México.,Centro de Investigación Biomédica de Michoacán, Instituto Mexicano del Seguro Social, Morelia, México
| | - Diego Bulcão Visco
- Instituto Tecnológico Superior de Tacámbaro, Michoacán, México.,Centro de Investigación Biomédica de Michoacán, Instituto Mexicano del Seguro Social, Morelia, México.,Departamento de Nutrição, Universidade Federal de Pernambuco, Recife, Brasil.,Unidade de Estudos em Nutrição e Plasticidade Fenotípica do Departamento de Nutrição, Universidade Federal de Pernambuco, Recife, Brazil
| | - Raul Manhães-de-Castro
- Departamento de Nutrição, Universidade Federal de Pernambuco, Recife, Brasil.,Unidade de Estudos em Nutrição e Plasticidade Fenotípica do Departamento de Nutrição, Universidade Federal de Pernambuco, Recife, Brazil
| | - Mercedes V Urquiza-Martínez
- Facultad de Químico-Farmacobiología, Universidad Michoacana de San Nicolás de Hidalgo, Morelia, México.,Centro de Investigación Biomédica de Michoacán, Instituto Mexicano del Seguro Social, Morelia, México
| | - Luis Miguel Saavedra
- Centro de Investigación Biomédica de Michoacán, Instituto Mexicano del Seguro Social, Morelia, México
| | - Mari C González-Vargas
- Instituto Tecnológico Superior de Tacámbaro, Michoacán, México.,Centro de Investigación Biomédica de Michoacán, Instituto Mexicano del Seguro Social, Morelia, México
| | - Rosalio Mercado-Camargo
- Facultad de Químico-Farmacobiología, Universidad Michoacana de San Nicolás de Hidalgo, Morelia, México
| | - Jailane de Souza Aquino
- Laboratório de Nutrição Experimental, Departamento de Nutrição, Universidade Federal da Paraíba, João Pessoa, Brazil
| | - Ana E Toscano
- Unidade de Estudos em Nutrição e Plasticidade Fenotípica do Departamento de Nutrição, Universidade Federal de Pernambuco, Recife, Brazil.,Departmento de Enfermagem, Universidade Federal de Pernambuco, Recife, Brasil.,Pós-Graduação em Neuropsiquiatria e Ciências do Comportamento, Universidade Federal de Pernambuco, Recife, Brasil
| | - Luz Torner
- Centro de Investigación Biomédica de Michoacán, Instituto Mexicano del Seguro Social, Morelia, México
| | - Omar Guzmán-Quevedo
- Instituto Tecnológico Superior de Tacámbaro, Michoacán, México.,Centro de Investigación Biomédica de Michoacán, Instituto Mexicano del Seguro Social, Morelia, México.,Pós-Graduação em Neuropsiquiatria e Ciências do Comportamento, Universidade Federal de Pernambuco, Recife, Brasil
| |
Collapse
|
4
|
Joly-Amado A, Soty M, Philippe E, Lacombe A, Castel J, Pillot B, Vily-Petit J, Zitoun C, Mithieux G, Magnan C. Portal Glucose Infusion, Afferent Nerve Fibers, and Glucose and Insulin Tolerance of Insulin-Resistant Rats. J Nutr 2022; 152:1862-1871. [PMID: 35511216 DOI: 10.1093/jn/nxac097] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2021] [Revised: 01/19/2022] [Accepted: 04/26/2022] [Indexed: 11/14/2022] Open
Abstract
BACKGROUND The role of hepatoportal glucose sensors is poorly understood in the context of insulin resistance. OBJECTIVES We assessed the effects of glucose infusion in the portal vein on insulin tolerance in 2 rat models of insulin resistance, and the role of capsaicin sensitive nerves in this signal. METHODS Male Wistar rats, 8 weeks old, weighing 250-275 g, were used. Insulin and glucose tolerance were assessed following a 4-hour infusion of either glucose or saline through catheterization in the portal vein in 3 paradigms. In experiment 1, for diet-induced insulin resistance, rats were fed either a control diet (energy content: proteins = 22.5%, carbohydrates = 64.1%, and lipids = 13.4%) or a high-fat diet (energy content: proteins = 15.3%, carbohydrates = 40.3%, and lipids =44.4%) for 4 months. In experiment 2, for centrally induced peripheral insulin resistance, catheters were inserted in the carotid artery to deliver either an emulsion of triglycerides [intralipid (IL)] or saline towards the brain for 24 hours. In experiment 3, for testing the role of capsaicin-sensitive nerves, experiment 2 was repeated following a periportal treatment with capsaicin or vehicle. RESULTS In experiment 1, when compared to rats fed the control diet, rats fed the high-fat diet exhibited decreased insulin and glucose tolerance (P ≤ 0.05) that was restored with a glucose infusion in the portal vein (P ≤ 0.05). In experiment 2, infusion of a triglyceride emulsion towards the brain (IL rats) decreased insulin and glucose tolerance and increased hepatic endogenous production when compared to saline-infused rats (P ≤ 0.05). Glucose infusion in the portal vein in IL rats restored insulin and glucose tolerance, as well as hepatic glucose production, to controls levels (P ≤ 0.05). In experiment 3, portal infusion of glucose did not increase insulin tolerance in IL rats that received a periportal pretreatment with capsaicin. CONCLUSIONS Stimulation of hepatoportal glucose sensors increases insulin tolerance in rat models of insulin resistance and requires the presence of capsaicin-sensitive nerves.
Collapse
Affiliation(s)
- Aurélie Joly-Amado
- Université de Paris, Functional and Adaptive Biology Unit, UMR (Unite Mixte de Recherche) 8251, CNRS (Centre National de la Recherche Scientifique), Paris, France
| | - Maud Soty
- Institut National de la Santé et de la Recherche Médicale, Lyon, France.,Université de Lyon, Lyon, France.,Université Lyon I, Villeurbanne, France
| | - Erwann Philippe
- Université de Paris, Functional and Adaptive Biology Unit, UMR (Unite Mixte de Recherche) 8251, CNRS (Centre National de la Recherche Scientifique), Paris, France
| | - Amelie Lacombe
- Université de Paris, Functional and Adaptive Biology Unit, UMR (Unite Mixte de Recherche) 8251, CNRS (Centre National de la Recherche Scientifique), Paris, France
| | - Julien Castel
- Université de Paris, Functional and Adaptive Biology Unit, UMR (Unite Mixte de Recherche) 8251, CNRS (Centre National de la Recherche Scientifique), Paris, France
| | - Bruno Pillot
- Institut National de la Santé et de la Recherche Médicale, Lyon, France.,Université de Lyon, Lyon, France.,Université Lyon I, Villeurbanne, France
| | - Justine Vily-Petit
- Institut National de la Santé et de la Recherche Médicale, Lyon, France.,Université de Lyon, Lyon, France.,Université Lyon I, Villeurbanne, France
| | - Carine Zitoun
- Institut National de la Santé et de la Recherche Médicale, Lyon, France.,Université de Lyon, Lyon, France.,Université Lyon I, Villeurbanne, France
| | - Gilles Mithieux
- Institut National de la Santé et de la Recherche Médicale, Lyon, France.,Université de Lyon, Lyon, France.,Université Lyon I, Villeurbanne, France
| | - Christophe Magnan
- Université de Paris, Functional and Adaptive Biology Unit, UMR (Unite Mixte de Recherche) 8251, CNRS (Centre National de la Recherche Scientifique), Paris, France
| |
Collapse
|
5
|
Boccia L, Borner T, Ghidewon MY, Kulka P, Piffaretti C, Doebley SA, De Jonghe BC, Grill HJ, Lutz TA, Le Foll C. Hypophagia induced by salmon calcitonin, but not by amylin, is partially driven by malaise and is mediated by CGRP neurons. Mol Metab 2022; 58:101444. [PMID: 35091058 PMCID: PMC8873943 DOI: 10.1016/j.molmet.2022.101444] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/08/2021] [Revised: 01/07/2022] [Accepted: 01/19/2022] [Indexed: 11/29/2022] Open
Abstract
Objective The behavioral mechanisms and the neuronal pathways mediated by amylin and its long-acting analog sCT (salmon calcitonin) are not fully understood and it is unclear to what extent sCT and amylin engage overlapping or distinct neuronal subpopulations to reduce food intake. We here hypothesize that amylin and sCT recruit different neuronal population to mediate their anorectic effects. Methods Viral approaches were used to inhibit calcitonin gene-related peptide (CGRP) lateral parabrachial nucleus (LPBN) neurons and assess their role in amylin’s and sCT’s ability to decrease food intake in mice. In addition, to test the involvement of LPBN CGRP neuropeptidergic signaling in the mediation of amylin and sCT’s effects, a LPBN site-specific knockdown was performed in rats. To deeper investigate whether the greater anorectic effect of sCT compared to amylin is due do the recruitment of additional neuronal pathways related to malaise multiple and distinct animal models tested whether amylin and sCT induce conditioned avoidance, nausea, emesis, and conditioned affective taste aversion. Results Our results indicate that permanent or transient inhibition of CGRP neurons in LPBN blunts sCT-, but not amylin-induced anorexia and neuronal activation. Importantly, sCT but not amylin induces behaviors indicative of malaise including conditioned affective aversion, nausea, emesis, and conditioned avoidance; the latter mediated by CGRPLPBN neurons. Conclusions Together, the present study highlights that although amylin and sCT comparably decrease food intake, sCT is distinctive from amylin in the activation of anorectic neuronal pathways associated with malaise. CGRP neurons mediate the effect of the amylin agonist salmon calcitonin (sCT) on food intake. Amylin's hypophagic effect does not require CGRP neurons. sCT-induced anorexia but not amylin is associated with malaise.
Collapse
Affiliation(s)
- Lavinia Boccia
- Institute of Veterinary Physiology, Vetsuisse Faculty, University of Zurich (UZH), 8057, Zurich, Switzerland
| | - Tito Borner
- Department of Biobehavioral Health Sciences, University of Pennsylvania, School of Nursing, Philadelphia, PA 19104, United States; Department of Psychiatry, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, United States
| | - Misgana Y Ghidewon
- Institute of Diabetes, Obesity and Metabolism and School of Arts and Sciences, University of Pennsylvania, Philadelphia, PA 19104, United States
| | - Patricia Kulka
- Institute of Veterinary Physiology, Vetsuisse Faculty, University of Zurich (UZH), 8057, Zurich, Switzerland
| | - Chiara Piffaretti
- Institute of Veterinary Physiology, Vetsuisse Faculty, University of Zurich (UZH), 8057, Zurich, Switzerland
| | - Sarah A Doebley
- Department of Biobehavioral Health Sciences, University of Pennsylvania, School of Nursing, Philadelphia, PA 19104, United States
| | - Bart C De Jonghe
- Department of Biobehavioral Health Sciences, University of Pennsylvania, School of Nursing, Philadelphia, PA 19104, United States; Department of Psychiatry, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, United States
| | - Harvey J Grill
- Institute of Diabetes, Obesity and Metabolism and School of Arts and Sciences, University of Pennsylvania, Philadelphia, PA 19104, United States
| | - Thomas A Lutz
- Institute of Veterinary Physiology, Vetsuisse Faculty, University of Zurich (UZH), 8057, Zurich, Switzerland
| | - Christelle Le Foll
- Institute of Veterinary Physiology, Vetsuisse Faculty, University of Zurich (UZH), 8057, Zurich, Switzerland.
| |
Collapse
|